Trials / Completed
CompletedNCT02662998
Validation of uHear™ as a Screening Tool to Detect Hearing Impairment in Older Cancer Patients Within a Comprehensive Geriatric Assessment - BIS
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (actual)
- Sponsor
- General Hospital Groeninge · Academic / Other
- Sex
- All
- Age
- 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to validate uHear™, an iOS-based tool, as a screening tool to detect significant hearing impairment as part of a comprehensive geriatric assessment in patients aged 70 years and older. The pass or fail screening cut-off is defined as having two or more consecutive hearing grades starting from the moderate-severe threshold zone ranging from 0.5 - 2.0 kHz.
Conditions
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2016-01-26
- Last updated
- 2018-02-15
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02662998. Inclusion in this directory is not an endorsement.